We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
AUM
$132M
AUM Growth
+$9.81M
Cap. Flow
+$3.88M
Cap. Flow %
2.93%
Top 10 Hldgs %
31.07%
Holding
141
New
8
Increased
35
Reduced
44
Closed
7

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.21%
2 Real Estate 16.84%
3 Healthcare 12.91%
4 Technology 12.84%
5 Financials 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
M icon
101
Macy's
M
$5.92B
$241K 0.18%
6,500
-1,500
-19% -$54.4K
FALC
102
DELISTED
FalconStor Software Inc
FALC
$231K 0.17%
222,100
-80,000
-26% -$83.6K
GDXJ icon
103
VanEck Junior Gold Miners ETF
GDXJ
$9.92B
$230K 0.17%
5,200
QQQ icon
104
Invesco QQQ Trust
QQQ
$493B
$228K 0.17%
1,920
FDX icon
105
FedEx
FDX
$78.4B
$227K 0.17%
+1,300
New +$213K
PBA icon
106
Pembina Pipeline
PBA
$28.1B
$216K 0.16%
7,100
KTOS icon
107
Kratos Defense & Security Solutions
KTOS
$10.1B
$189K 0.14%
27,500
-10,000
-27% -$58.4K
RMTI icon
108
Rockwell Medical
RMTI
$31.2M
$188K 0.14%
255
FAX
109
abrdn Asia-Pacific Income Fund
FAX
$602M
$182K 0.14%
5,917
-33
-0.6% -$1.03K
UVXY icon
110
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$272M
0
CIFC
111
DELISTED
CIFC LLC Common Shares
CIFC
$141K 0.11%
12,640
-330
-3% -$2.95K
ESI icon
112
Element Solutions
ESI
$8.9B
$134K 0.1%
16,500
+5,000
+43% +$44.6K
GALT icon
113
Galectin Therapeutics
GALT
$418M
$134K 0.1%
118,200
+58,600
+98% +$104K
CNTY icon
114
Century Casinos
CNTY
$34.6M
$121K 0.09%
17,500
VATE icon
115
INNOVATE Corp
VATE
$106M
$109K 0.08%
+2,000
New +$92.2K
AXGN icon
116
Axogen
AXGN
$2.78B
$104K 0.08%
11,500
-500
-4% -$4.07K
FIG
117
DELISTED
Fortress Investment Group Llc
FIG
$99K 0.07%
20,000
NUWE icon
118
Nuwellis
NUWE
$3.14M
0
BLRX
119
BioLineRX
BLRX
$12.1M
$51K 0.04%
73
XTIA icon
120
XTI Aerospace
XTIA
$53.1M
0
APDNW
121
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$18K 0.01%
16,000
BLIN icon
122
Bridgeline Digital
BLIN
$12.4M
$16K 0.01%
80
+40
+100% +$8.51K
PDL.B
123
DELISTED
PRESIDENTAL RLTY CL B
PDL.B
$1K ﹤0.01%
30,700
JCI icon
124
Johnson Controls International
JCI
$86.1B
-17,715
Closed -$821K
KMI icon
125
Kinder Morgan
KMI
$70.2B
-14,081
Closed -$264K

Similar funds

Benchmark Capital Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Benchmark Capital Advisors held 141 positions worth $132M, up 8% from $123M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Benchmark Capital Advisors's Q3 2016 filing shows 8 new, 35 increased, 44 reduced and 7 closed positions. Its largest new stake was Alibaba: 17,570 shares worth $1.86M. The largest sale was Sarepta Therapeutics, an estimated $1.73M.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 18% a quarter earlier, followed by Real Estate and Healthcare.

  • Benchmark Capital Advisors's largest Q3 2016 buy was Alibaba: 17,570 shares worth $1.86M.
  • Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q3 2016, an estimated $1.55M increase.
  • Benchmark Capital Advisors's biggest Q3 2016 reduction was Sarepta Therapeutics, cutting an estimated $1.73M.
  • Benchmark Capital Advisors fully exited Johnson Controls International in Q3 2016, selling an estimated $821K.
  • Benchmark Capital Advisors's ten largest holdings make up 31% of its $132M portfolio in Q3 2016.
  • Benchmark Capital Advisors opened 8 new positions and closed 7 in Q3 2016.
  • Benchmark Capital Advisors's portfolio value rose 8% quarter-over-quarter to $132M.

Based on Benchmark Capital Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.